159 related articles for article (PubMed ID: 1887669)
1. Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone.
Budowsky EI; Friedman EA; Zheleznova NV; Noskov FS
Vaccine; 1991 Jun; 9(6):398-402. PubMed ID: 1887669
[TBL] [Abstract][Full Text] [Related]
2. Principles of selective inactivation of viral genome. V. Rational selection of conditions for inactivation of the viral suspension infectivity to a given extent by the action of beta-propiolactone.
Budowsky EI; Zalesskaya MA
Vaccine; 1991 May; 9(5):319-25. PubMed ID: 1872015
[TBL] [Abstract][Full Text] [Related]
3. Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus.
Budowsky EI; Smirnov YuA ; Shenderovich SF
Vaccine; 1993; 11(3):343-8. PubMed ID: 8447162
[TBL] [Abstract][Full Text] [Related]
4. Principles of selective inactivation of viral genome. VII. Some peculiarities in determination of viral suspension infectivity during inactivation by chemical agents.
Budowsky EI; Friedman EA; Zheleznova NV
Vaccine; 1991 Jul; 9(7):473-6. PubMed ID: 1897304
[TBL] [Abstract][Full Text] [Related]
5. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone].
Budovskiĭ EI; Zalesskaia MA
Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
Sasaki Y; Yoshino N; Sato S; Muraki Y
J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus: an NMR study of mechanisms involved in infection.
Mountford CE; Grossman G; Hampson AW; Holmes KT
Biochim Biophys Acta; 1982 Feb; 720(1):65-74. PubMed ID: 7059616
[TBL] [Abstract][Full Text] [Related]
9. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
Herrera-Rodriguez J; Signorazzi A; Holtrop M; de Vries-Idema J; Huckriede A
Vaccine; 2019 Mar; 37(12):1630-1637. PubMed ID: 30765167
[TBL] [Abstract][Full Text] [Related]
10. Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.
Bonnafous P; Nicolaï MC; Taveau JC; Chevalier M; Barrière F; Medina J; Le Bihan O; Adam O; Ronzon F; Lambert O
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):355-63. PubMed ID: 24140008
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum.
King DJ
Avian Dis; 1991; 35(3):505-14. PubMed ID: 1835374
[TBL] [Abstract][Full Text] [Related]
12. Principles of selective inactivation of viral genome. I. UV-induced inactivation of influenza virus.
Budowsky EI; Bresler SE; Friedman EA; Zheleznova NV
Arch Virol; 1981; 68(3-4):239-47. PubMed ID: 7271457
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
14. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
[TBL] [Abstract][Full Text] [Related]
15. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of poliovirus with beta-propiolactone.
Jiang SD; Pye D; Cox JC
J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
[TBL] [Abstract][Full Text] [Related]
17. Potential hazards associated with influenza virus vaccines.
Scholtissek C
Dev Biol Stand; 1995; 84():55-8. PubMed ID: 7796968
[TBL] [Abstract][Full Text] [Related]
18. Reproduction of influenza viruses; quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction.
HORSFALL FL
J Exp Med; 1955 Oct; 102(4):441-73. PubMed ID: 13263486
[TBL] [Abstract][Full Text] [Related]
19. Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.
Hughes K; Zachertowska A; Wan S; Li L; Klimaszewski D; Euloth M; Hatchette TF
Vaccine; 2007 May; 25(22):4456-63. PubMed ID: 17418461
[TBL] [Abstract][Full Text] [Related]
20. Effects of several virucidal agents on inactivation of influenza, Newcastle disease, and avian infectious bronchitis viruses in the allantoic fluid of chicken eggs.
Abe M; Kaneko K; Ueda A; Otsuka H; Shiosaki K; Nozaki C; Goto S
Jpn J Infect Dis; 2007 Nov; 60(6):342-6. PubMed ID: 18032831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
